{
    "clinical_study": {
        "@rank": "168023", 
        "acronym": "RAMSES", 
        "arm_group": [
            {
                "arm_group_label": "Drug elluting Balloon (DEB)", 
                "arm_group_type": "Experimental", 
                "description": "Is a coronary dilating device with Paclitaxel \u00ae drug delivery,   for dilatation and provisional spot bare metal stenting (BMS)."
            }, 
            {
                "arm_group_label": "Drug elluting coronary stent (DES)", 
                "arm_group_type": "Active Comparator", 
                "description": "The Resolute Integrity Zotarolimus-Eluting Coronary Stent System is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions of length \u2264 27 mm in native coronary arteries with reference vessel diameters of 2.25 mm to 4.20 mm."
            }
        ], 
        "brief_summary": {
            "textblock": "Significant lesions in small coronary arteries are frequently found (35%-50%) in patients\n      with coronary artery disease. Independently of the type of coronary angioplasty the\n      restenosis and the need for repeat revascularization remains the main limitation,\n      representing a challenging problem even in the DES (drug eluting stent) era. Recently has\n      been developed drug eluting balloons (DEBs), which have been successfully tested in small\n      series on in-stent restenosis, but few evidence is available in the context of small vessels\n      disease.\n\n      The current study has been designed to know, in one hand, the clinical efficacy of the Drug\n      elluting balloon IN.PACT FALCON and, in other hand, the effectiveness, and the\n      cost-effectiveness incremental analysis of DEBs (IN.PACT FALCON vs. DES ( RESOLUTE\n      INTEGRITY) in patients with de novo lesions in small vessels."
        }, 
        "brief_title": "Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon.", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Disease", 
                "Coronary Artery Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Recent studies have reported the efficacy of the local application of paclitaxel \u00ae\n      inhibiting neointimal proliferation, and thus the limitation of restenosis, which has led to\n      the conception and development of drug-coated balloon or \"Drug Eluting Balloons\" (DEB),\n      releasing the antiproliferative drug at the time of expansion. Initially they were applied\n      in the treatment of in-stent restenosis. However, DEB may represent a therapeutic\n      alternative in other contexts where anatomo-clinical uses are not always therapeutic\n      percutaneous coronary revascularization with stent implantation, as is the case of coronary\n      lesions located in small vessels."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Older than 18, informed consent.\n\n          2. Evidence of CAD with severe de novo lesion in the native coronary arteries ( \u226570%\n             stenosis by visual estimation or >50% by CT scan); affecting\n\n          3. Vessels between 2,25 and 2,75 mm diameter and\n\n          4. The length of the coronary stenosis \u226425 mm\n\n          5. Patient informed consent form signed.\n\n        Exclusion Criteria:\n\n          1. Lesion in coronary left main ,\n\n          2. Chronic total occlusions,\n\n          3. Lesions at bifurcation,\n\n          4. Severe calcified lesions,\n\n          5. Lesions  in aorto-coronary saphenous veins or arterial grafts,\n\n          6. Acute Myocardial Infarction during 48 hours before the procedure,\n\n          7. Severe renal dysfunction,\n\n          8. Hypersensibility, allergy or contraindication of medication: acetylsalicylic acid,\n             clopidogrel, ticlopidine, heparin, paclitaxel,\n\n          9. Allergy to contrast media,\n\n         10. Life expectancy less than 1 year,\n\n         11. 1 year FU not guaranteed,\n\n         12. Being participating in another study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "290", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01722799", 
            "org_study_id": "MEIX-STENT-001", 
            "secondary_id": "RAMSES-DEB"
        }, 
        "intervention": [
            {
                "arm_group_label": "Drug elluting Balloon (DEB)", 
                "description": "Percutaneous transluminal coronary angioplasty with drug elluting ballon and Bare metal stent for rescue.", 
                "intervention_name": "Drug elluting Balloon (DEB)", 
                "intervention_type": "Device", 
                "other_name": "IN.PACT\u2122 Falcon paclitaxel eluting balloon."
            }, 
            {
                "arm_group_label": "Drug elluting coronary stent (DES)", 
                "description": "Percutaneous transluminal coronary angioplasty (PTCA) with stent", 
                "intervention_name": "Drug elluting coronary stent (DES)", 
                "intervention_type": "Device", 
                "other_name": "Resolute integrity\u2122 zotarolimus drug coronary stent"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Paclitaxel"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "angioplasty", 
            "Percutaneous Transluminal Coronary Angioplasty", 
            "Drug elluting Balloon", 
            "Coronary Balloon", 
            "Dilatation"
        ], 
        "lastchanged_date": "May 10, 2013", 
        "link": {
            "description": "Web Page from Cardiology department.Hospital Meixoeiro.", 
            "url": "http://www.cardiologia-vigo.com"
        }, 
        "location": {
            "contact": {
                "email": "carlos.maria.diaz.lopez@sergas.es", 
                "last_name": "Carlos M. D\u00edaz-L\u00f3pez, MSC", 
                "phone": "0986811163", 
                "phone_ext": "211163"
            }, 
            "contact_backup": {
                "email": "victor.alfonso.jimenez.diaz@sergas.es", 
                "last_name": "Victor A. Jimenez-Diaz, MSC", 
                "phone": "0986811163"
            }, 
            "facility": {
                "address": {
                    "city": "Vigo", 
                    "country": "Spain", 
                    "state": "Pontevedra", 
                    "zip": "36214"
                }, 
                "name": "Complejo hospitalario universitario de vigo"
            }, 
            "investigator": [
                {
                    "last_name": "Andres I\u00f1iguez, Romo", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Victor A. Jimenez Diaz, MSC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jose A. Baz Alonso, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "PROSPECTIVE RANDOMIZED TRIAL Multicentric Study to Evaluate the Treatment and the Efficiency of Paclitaxel-coated Balloon IN.PACT FALCON \u00ae in Small-vessel Coronary Stenosis.", 
        "overall_contact": {
            "email": "carlos.maria.diaz.lopez@sergas.es", 
            "last_name": "Carlos M. D\u00edaz L\u00f3pez, MSC", 
            "phone": "986811163", 
            "phone_ext": "211758"
        }, 
        "overall_contact_backup": {
            "email": "victor.alfonso.jimenez.diaz@sergas.es", 
            "last_name": "Victor A. Jimenez D\u00edaz, MSC", 
            "phone": "986811163", 
            "phone_ext": "211758"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital de Meixoeiro", 
                "last_name": "Andres I\u00f1iguez Romo, PHD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital de Meixoeiro", 
                "last_name": "Victor A. Jimenez Diaz, MSC", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Hospital de Meixoeiro", 
                "last_name": "Carlos M Diaz Lopez, MSC", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Hospital Cl\u00ednico San Carlos", 
                "last_name": "Carlos Macaya Miguel, PHD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Virgen de la Arrixaca", 
                "last_name": "Mariano Valdes Ch\u00e1varri., PHD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital General Yag\u00fce", 
                "last_name": "Juan M Dur\u00e1n Hern\u00e1ndez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Juan Ramon Jimenez", 
                "last_name": "Dr. Jos\u00e9 F D\u00edaz Hern\u00e1ndez., MD.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Son Espases", 
                "last_name": "Armando Bethencourt Gonz\u00e1lez, PHD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Virgen de la Victoria", 
                "last_name": "Jose M. Hern\u00e1ndez Garc\u00eda., MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Virgen de las Nieves", 
                "last_name": "Eduardo Molina Navarro, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Virgen de la Candelaria", 
                "last_name": "Francisco Bosa Ojeda, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital San Creu i San Pau", 
                "last_name": "Antoni Serra Pe\u00f1aranda., MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Centro Hospitalar de Lisboa (Hospital Sta Cruz)", 
                "last_name": "Manuel De Sousa Almeida, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Virgen de la Macarena", 
                "last_name": "Rafael Ruiz Salmer\u00f3n, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Lisboa Central (Hospital Sta Marta)", 
                "last_name": "Rui Cruz Ferreira., MD.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital de Meixoeiro", 
                "last_name": "Andres I\u00f1iguez Romo, PHD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Target vessel failure (TVF) is define as any revascularization motivated due to myocardial infarction (with or without Q wave) or cardiac death related to the target vessel.", 
                "measure": "Compare the clinical efficacy measured by target vessel failure of DEB IN.PACT FALCON DEB versus the resolute integrity stent (DES).", 
                "safety_issue": "No", 
                "time_frame": "The efficacy will be evaluated at  1 year."
            }, 
            {
                "description": "Rate of major adverse cardiac events (MACE) at 30 days, 6 months and one year. MACE was defined as cardiac death, myocardial infarction (MI) (with or without Q-wave), need for repeat revascularization of the treated vessel (surgical or repeat PCI) or occlusion of the treated lesion.", 
                "measure": "Compare the clinical security measured by the incidence MACE of DEB IN.PACT FALCON DEB versus the resolute integrity stent (DES).", 
                "safety_issue": "Yes", 
                "time_frame": "The security will be evaluated at one month, sixth month and one year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01722799"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital de Meixoeiro", 
            "investigator_full_name": "Andres I\u00f1iguez Romo, MD, PhD", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "20081769", 
                "citation": "Tepe G, Schmitmeier S, Speck U, Schnorr B, Kelsch B, Scheller B. Advances on drug-coated balloons. J Cardiovasc Surg (Torino). 2010 Feb;51(1):125-43. Review."
            }, 
            {
                "PMID": "20948503", 
                "citation": "Schnorr B, Kelsch B, Cremers B, Clever YP, Speck U, Scheller B. Paclitaxel-coated balloons - Survey of preclinical data. Minerva Cardioangiol. 2010 Oct;58(5):567-82. Review."
            }, 
            {
                "PMID": "19487593", 
                "citation": "Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009 Jun 16;119(23):2986-94. Epub 2009 Jun 1."
            }
        ], 
        "secondary_outcome": [
            {
                "description": "In order to perform a cost-utility analysis, years of quality-adjusted life (QALY) gained will be measured using the quality of life questionnaire EuroQoL five dimensions (EQ-5D) and a visual scale at baseline, one month and 12 months.", 
                "measure": "Compare the efficiency of DEBs versus DES. in terms of cost effectiveness (cost per adverse event-death avoided) and cost-utility ( cost per quality adjusted life year) in patients with de novo lesions in small vessels.", 
                "safety_issue": "No", 
                "time_frame": "The efficiency will be evaluated at first month, 6 month and 1 year."
            }, 
            {
                "measure": "Compare the direct cost, indirect costs and total costs of DEBs versus DES in patients with de novo lesions in small vessels.", 
                "safety_issue": "No", 
                "time_frame": "This outcome will be evaluated at first month, 6 month and 1 year."
            }
        ], 
        "source": "Hospital de Meixoeiro", 
        "sponsors": {
            "collaborator": {
                "agency": "Hospital de Meixoeiro", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Andres I\u00f1iguez Romo, MD, PhD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}